Notes to Editors
Biocompatibles International plc is a leading medical technology company in the field of drug-device combination products, operating through three businesses. The International Division conducts the marketing of Biocompatibles’ approved products – Biocompatibles’ Drug-Eluting Bead products which are used in the treatment of primary and secondary liver cancers and BrachySciences’ radiation-delivering seeds which are used in the treatment of prostate cancer.
The Drug Delivery Division and CellMed are engaged in new product development and licensing. The Drug Delivery Division is developing new products for oncology and other indications, based on the company’s core drug delivery technologies. CellMed is developing a Bead product for cosmetic dermatology and a Drug-Eluting Bead product for the treatment of stroke, based on proprietary stem cell technology.
Our strategic partners include Angiodynamics Inc, Medtronic Inc, Merz Pharmaceuticals GmbH and Terumo Corporation.
Biocompatibles has indicated that 2008 revenues are expected to be in the range of £15m to £17m; and that year end cash is expected to be approximately £28m.